Hormone replacement therapy is associated with decreased survival in women with lung cancer

Journal of Clinical Oncology

Volumn 24, Issue 1, 2006, Pages 59-63

  Ganti, Apar Kishor ^a   Sahmoun, Abe E ^a   Panwalkar, Amit W ^a   Tendulkar, Ketki K ^a   Potti, Anil ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOKING; ESTROGEN THERAPY; FEMALE; LUNG TUMOR; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; SMOKING;

EID: 33644838866     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.9827     Document Type: Article

References (23)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 55:10-30, 2005
2. Wingo PA, Ries LA, Giovino GA, et al: The annual report to the nation on the status of cancer 1973-1996 with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 91:675-690, 1999
3. Risch HA, Howe GR, Jain M, et al: Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol 138:281-293, 1993
4. Harris RE, Zang EA, Anderson JI, et al: Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol 22:592-599, 1993
5. Gasperino J, Rom WN: Gender and lung cancer. Clin Lung Cancer 5:353-359, 2004
6. Schoenberg JB, Wilcox HB, Mason TJ, et al: Variation in smoking-related lung cancer risk among New Jersey women. Am J Epidemiol 130:688-695, 1989
7. Bain C, Feskanich D, Speizer FE, et al: Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 96:826-334, 2004
8. US Department of Health and Human Services: The Health Consequences of Smoking: A Report of the Surgeon General. Washington, DC, US Department of Health and Human Services, Public Health Service, Center for Disease Control, publication No. 7829, 2004
9. Adami HO, Persson I, Hoover R, et al: Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 44:833-839, 1989
10. Taioli E, Wynder EL: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 86:869-870, 1994
11. Blackman JA, Coogan PF, Rosenberg L, et al: Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf 11:561-567, 2002
12. Kreuzer M, Gerken M, Heinrich J, et al: Hormonal factors and risk of lung cancer among women? Int J Epidemiol 32:263-271, 2003
13. Schabath MB, Wu X, Vassilopoulou-Sellin R, et al: Hormone replacement therapy and lung cancer risk: A case-control analysis. Clin Cancer Res 10: 113-123, 2004
14. Mollerup S, Jorgensen K, Berge G, et al: Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer 37:153-159, 2002
15. Stabile LP, Davis AL, Gubish CT, et al: Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 62:2141-2150, 2002
16. Stabile LP, Siegfried JM: Estrogen receptor pathways in lung cancer. Curr Oncol Rep 6:259-267, 2004
17. Coombes RC, Hall E, Gibson LJ, et al: Intergroup Exemestane Study: A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081-1092, 2004
18. Moore KA, Mery CM, Jaklitsch MT, et al: Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. Ann Thorac Surg 76:1789-1795, 2003
19. Ettinger B, Friedman GD, Bush T, et al: Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 87: 6-12, 1996
20. Wei Q, Cheng L, Amos CI, et al: Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study. J Natl Cancer Inst 92:1764-1772, 2000
21. Nelson HH, Christiani DC, Mark EJ, et al: Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 91:2032-2038, 1999
22. Shriver SP, Bourdeau HA, Gubish CT, et al: Sex-specific expression of gastrin-releasing peptide receptor: Relationship to smoking history and risk of lung cancer. J Natl Cancer Inst 92:24-33, 2000
23. Balsara BR, Sonoda G, du Manoir S, et al: Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 57: 2116-2120, 1997